Kết quả tìm kiếm - Gideon Bollag
- Đang hiển thị 1 - 20 kết quả của 48
- Chuyển đến trang tiếp theo
-
1
Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. Bằng Gideon Bollag, Frank McCormick, R Clark
Được phát hành 1993Artigo -
2
Discovery of a novel Raf kinase inhibitor. Bằng John F. Lyons, S M Wilhelm, Barbara Hibner, Gideon Bollag
Được phát hành 2001Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in<i>BRAF</i>Mutant Thyroid Carcinoma Cells Bằng Paolo Salerno, Valentina De Falco, Anna Tamburrino, Tito Claudio Nappi, Giancarlo Vecchio, Rebecca E. Schweppe, Gideon Bollag, Massimo Santoro, Giuliana Salvatore
Được phát hành 2009Artigo -
10
The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT–dependent apoptosis in diffuse large B-cell lymphoma Bằng Peter G. Smith, Fengfei Wang, Kathryn Wilkinson, Kerry J. Savage, Ulf Klein, Donna Neuberg, Gideon Bollag, Margaret A. Shipp, Ricardo C.T. Aguiar
Được phát hành 2004Artigo -
11
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer Bằng Jingying Xu, Jemima Escamilla, Stephen Mok, John David, Saul J. Priceman, Brian L. West, Gideon Bollag, William H. McBride, Lily Wu
Được phát hành 2013Artigo -
12
-
13
-
14
Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase <i>BRAF</i> -mutant lung cancer Bằng Ross A. Okimoto, Luping Lin, Victor Olivas, Elton Chan, Evan Markegard, Andrey Rymar, Dana S. Neel, Xiaohong Chen, Golzar Hemmati, Gideon Bollag, Trever G. Bivona
Được phát hành 2016Artigo -
15
Targeting BRAFV600E with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer Bằng Carmelo Nucera, Matthew A. Nehs, Sushruta S. Nagarkatti, Peter M. Sadow, Michal Mekel, Andrew H. Fischer, Paul Lin, Gideon Bollag, Jack Lawler, Richard A. Hodin, Sareh Parangi
Được phát hành 2011Artigo -
16
PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas Bằng John Tayu Lee, Ling Li, Patricia Brafford, Marcia van den Eijnden, Molly B. Halloran, Katrin Sproesser, Nikolas K. Haass, Keiran S.M. Smalley, James Tsai, Gideon Bollag, Meenhard Herlyn
Được phát hành 2010Artigo -
17
Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer Bằng Hong Yang, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, William D. Bradley, Richard J. Lee, Kathleen Schostack, Mary Ellen Simcox, Scott Kopetz, David Heimbrook, Brian Lestini, Gideon Bollag, Fei Su
Được phát hành 2011Artigo -
18
Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma Bằng William D. Tap, Ke-Wei Gong, Judy Daring, Yiou Tseng, Charles Ginther, Giovanni M. Pauletti, John A. Glaspy, Richard Essner, Gideon Bollag, Peter Hirth, Chao Zhang, Dennis J. Slamon
Được phát hành 2010Artigo -
19
BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model Bằng Daniele Perna, Florian A. Karreth, Alistair G. Rust, Pedro A. Pérez–Mancera, Mamunur Rashid, Francesco Iorio, Constantine Alifrangis, Mark J. Arends, Marcus Bosenberg, Gideon Bollag, David A. Tuveson, David J. Adams
Được phát hành 2015Artigo -
20
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition Bằng Carlos E. Prada, Edwin Jousma, Tilat A. Rizvi, Jianqiang Wu, R. Scott Dunn, Debra A. Mayes, José A. Cancelas, Eva Dombi, Mi‐Ok Kim, Brian L. West, Gideon Bollag, Nancy Ratner
Được phát hành 2012Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Biology
Cancer research
Gene
Medicine
Genetics
Cancer
Kinase
Internal medicine
Biochemistry
Cell biology
Mutation
Signal transduction
MAPK/ERK pathway
Melanoma
KRAS
Mutant
V600E
Metastatic melanoma
Vemurafenib
Chemistry
Cell cycle
Protein kinase A
Colorectal cancer
Oncogene
Pathology
Receptor
Endocrinology
Immunology
Oncology
PI3K/AKT/mTOR pathway